Bad Weed

A Case of Prolonged Psychosis Secondary to Synthetic Cannabinoids

Authors

  • Karen E. Moeller, Pharm.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS; University of Kansas School of Pharmacy, Department of Pharmacy Practice, Lawrence, KS
  • Nischal Sager, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS
  • Todd Mekles, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS
  • Amad Din, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS
  • Ann Genovese, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS
  • Sadiq Naveed, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS
  • Andrew Demo, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS

DOI:

https://doi.org/10.17161/kjm.v9i2.8607

Keywords:

cannabis, cannabinoids, psychotic disorders

Metrics

Metrics Loading ...

Downloads

Published

2019-01-08

Issue

Vol. 9 No. 2 (2016)

Section

Case Reports

License

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Moeller, K. E., Sager, N., Mekles, T., Din, A., Genovese, A., Naveed, S., & Demo, A. (2019). Bad Weed: A Case of Prolonged Psychosis Secondary to Synthetic Cannabinoids. Kansas Journal of Medicine, 9(2), 43-44. https://doi.org/10.17161/kjm.v9i2.8607